Success Metrics

Clinical Success Rate

86.8%

Based on 66 completed trials

Completion Rate

87%(66/76)

Active Trials

10(9%)

Results Posted

59%(39 trials)

Terminated

10(9%)

Phase Distribution

Ph phase_4

33%

Ph not_applicable

35%

Ph phase_3

10%

Ph early_phase_1

Ph phase_1

Ph phase_2

11%

Phase Distribution

Early Stage

Mid Stage

Late Stage

Phase Distribution108 total trials

Early Phase 1First-in-human

2(1.9%)

Phase 1Safety & dosage

9(8.3%)

Phase 2Efficacy & side effects

12(11.1%)

Phase 3Large-scale testing

11(10.2%)

Phase 4Post-market surveillance

36(33.3%)

N/ANon-phased studies

38(35.2%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

81.5%

66 of 81 finished

Non-Completion Rate

18.5%

15 ended early

Currently Active

trials recruiting

Total Trials

110

all time

Status Distribution

Active(13)

Completed(66)

Terminated(15)

Other(16)

Detailed Status

Completed66

unknown15

Terminated10

Recruiting6

Withdrawn5

Active, not recruiting4

Development Timeline

Analytics

Development Status

Total Trials

110

Active

Success Rate

86.8%

Most Advanced

Phase 4

Trials by Phase

Early Phase 12 (1.9%)

Phase 19 (8.3%)

Phase 212 (11.1%)

Phase 311 (10.2%)

Phase 436 (33.3%)

N/A38 (35.2%)

Trials by Status

suspended11%

terminated109%

active_not_recruiting44%

recruiting65%

withdrawn55%

completed6660%

not_yet_recruiting33%

unknown1514%

Recent Activity

10 active trials

Showing 5 of 110

recruitingphase_3

Intra-Prostatic Epinephrine Injection in Bipolar Transurethral Resection of Large Prostate: Exploring Its Role in Optimizing Surgical Outcomes

NCT07733167

active_not_recruitingphase_2

Randomized Phase II Trial of Rituximab With Either Pentostatin or Bendamustine for Multiply Relapsed or Refractory Hairy Cell Leukemia

NCT01059786

recruitingphase_3

Clinical Trials (110)

Showing 20 of 110 trialsScroll for more

NCT07733167Phase 3

Intra-Prostatic Epinephrine Injection in Bipolar Transurethral Resection of Large Prostate: Exploring Its Role in Optimizing Surgical Outcomes

Recruiting

NCT01059786Phase 2

Randomized Phase II Trial of Rituximab With Either Pentostatin or Bendamustine for Multiply Relapsed or Refractory Hairy Cell Leukemia

Active Not Recruiting

NCT07092566Phase 3

R.E.C.K vs Exparel in Robotic Nephrectomy

Recruiting

NCT07667829Not Applicable

Vasopressor Agents in Pulmonary Hypertension Crisis

Not Yet Recruiting

NCT04573751Not Applicable

The EPIVER Randomized Controlled Trial

Completed

NCT06418308Phase 4

Intrathecal Dexmedetomidine vs Epinephrine

Completed

NCT05972681Phase 4

The PAIN (Pelvic Area Injection for Numbness) Study

Terminated

NCT06416969Early Phase 1

Regional Lipolysis and Adipocyte Lipolysis Protein Stimulation

Recruiting

NCT00678145Phase 2

Mechanisms of Hypoglycemia Associated Autonomic Failure

Terminated

NCT04432597Phase 1

HPV Vaccine PRGN-2009 Alone or in Combination With Anti-PDL1/TGF-Beta Trap (M7824) in Subjects With HPV Associated Cancers

Active Not Recruiting

NCT05738148Phase 1

Vasopressin vs. Epinephrine During Neonatal Cardiopulmonary Resuscitation

Active Not Recruiting

NCT06112548Not Applicable

The Efficiency of Periarticular Multimodal Drug Injection in Pain Management Following Primary Unilateral TKA

Completed

NCT07144267Not Applicable

Comparison of Milrinone and Epinephrine on TAPSE

Not Yet Recruiting

NCT05488847Phase 4

Opioid-Free Pain Protocol After Shoulder Arthroplasty

Active Not Recruiting

NCT02118467Phase 4

Vasoactive Drugs in Intensive Care Unit

Recruiting

NCT03826524Phase 4

Epinephrine Dose: Optimal Versus Standard Evaluation Trial

Recruiting

NCT02692313Early Phase 1

Dose Response of Epinephrine

Completed

NCT02356159Phase 1

Study of Palifermin (Kepivance) in Persons Undergoing Unrelated Donor Allogeneic Hematopoietic Cell Transplantation

Completed

NCT02722746Phase 1

The Prevention of Hypotension After Epidural Analgesia After Major Surgery

Completed

NCT03554473Phase 1

M7824 and Topotecan or Temozolomide in Relapsed Small Cell Lung Cancers

Completed

Drug Details

Intervention Type: DRUG
Total Trials: 110